| CYSB2400335 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2025-01-01 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CYSB2400327 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2024-12-14 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CYSB2400312 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2024-12-04 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CYSB2400264 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2024-09-29 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CYSB2400093 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2024-04-19 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSB2400027 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-03-29 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2400009 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-01-31 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSS2400013 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2024-01-19 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CYSB2300230 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2023-12-09 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSB2300125 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-11-09 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSS2300086 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2023-10-13 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSS2300071 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2023-08-30 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2300534 | 替雷利珠单抗注射液（皮下注射） | tislelizumab | Injection | Biological Products(2.1) | New Drug Application | 2023-08-02 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd | | | view |
| CXSB2300077 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-08-01 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSL2300233 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2023-04-10 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2300019 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-02-24 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSL2300042 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2023-01-17 | | Baiji Shenzhou (Shanghai) Biotechnology Co Ltd | | | view |
| CXSB2300004 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products | Supplementary Application | 2023-01-11 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Baiji Shenzhou (Shanghai) Biotechnology Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CXSS2200095 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(2.2) | New Drug Application | 2022-12-31 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
| CYSB2200290 | 替雷利珠单抗注射液 | tislelizumab | Injection | Biological Products(1) | Supplementary Application | 2022-12-27 | | BeiGene Guangzhou Biologics Manufacturing Co Ltd;Boehringer Ingelheim Biopharmaceuticals (China) Ltd | | | view |
